| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/01/1998 | DE19713001A1 Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung Graminaenpollenallergenmutanten for specific immunotherapy, their preparation and use |
| 10/01/1998 | CA2287156A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 10/01/1998 | CA2285480A1 Screening method for proline-rich proteins |
| 10/01/1998 | CA2284844A1 A porin gene from campylobacter jejuni, related products and uses thereof |
| 10/01/1998 | CA2284687A1 Keratinocyte derived kallikrein |
| 10/01/1998 | CA2284671A1 Carbohydrate antigens which immunoreact with polyclonal antisera against h. pylori |
| 10/01/1998 | CA2284642A1 Methods and compositions for diagnosis and treatment of breast cancer |
| 10/01/1998 | CA2284611A1 Replication-competent herpes simplex viruses |
| 10/01/1998 | CA2284606A1 Method for generating saccharide fragments |
| 10/01/1998 | CA2284251A1 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 10/01/1998 | CA2284028A1 A method of preservation of vaccines with polybiguanide |
| 10/01/1998 | CA2283965A1 Composition comprising immunoglobulin |
| 10/01/1998 | CA2283762A1 Uronium salt conjugate vaccines |
| 10/01/1998 | CA2255765A1 Antigenic fusionprotein carrying gal.alpha.1,3gal epitopes |
| 10/01/1998 | CA2247075A1 Interferon related protein hkafe42 |
| 10/01/1998 | CA2233783A1 Anti-fas antibodies |
| 09/30/1998 | EP0867513A2 Interleukin-1 beta converting enzyme apoptosis protease-10 |
| 09/30/1998 | EP0867509A2 Tumor necrosis related receptor, TR5 |
| 09/30/1998 | EP0867508A2 Olfactory receptor of the 7-transmembrane receptor family - OLRCC15 receptor |
| 09/30/1998 | EP0867507A1 LicB polypeptides from Streptococcus pneumoniae |
| 09/30/1998 | EP0867451A2 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
| 09/30/1998 | EP0867438A1 Rapamycin derivatives and their use, particularly as immunosuppressants |
| 09/30/1998 | EP0867190A1 Novel toxin complex |
| 09/30/1998 | EP0867189A2 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
| 09/30/1998 | EP0867188A1 Microspheres containing immunogens, process for producing the same, and method for immunizing animals with the use of the same |
| 09/30/1998 | EP0866871A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 09/30/1998 | EP0866861A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 09/30/1998 | EP0866857A1 E6 binding proteins |
| 09/30/1998 | EP0866851A1 Tumour vaccine and process for the preparation thereof |
| 09/30/1998 | EP0866807A1 Porcine cell interaction proteins |
| 09/30/1998 | EP0866803A1 Transferrin receptor protein of moraxella |
| 09/30/1998 | EP0866726A1 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 09/30/1998 | EP0866721A1 Targeted adenovirus vectors |
| 09/30/1998 | EP0866718A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 09/30/1998 | EP0866695A1 Combinational therapeutic methods employing nitric oxide scavengers |
| 09/30/1998 | EP0866655A2 Murine model for human carcinoma |
| 09/30/1998 | EP0643769B1 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN $i(Phl p) II |
| 09/30/1998 | EP0551460B1 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV) |
| 09/30/1998 | CN1194651A Modified/chimeric superantigens and their use |
| 09/30/1998 | CN1194584A Method for industrially producing a Japanese encephalitis vaccine, and resulting vaccine |
| 09/29/1998 | US5814617 Vaccine to reduce the severity or incidence of infection by a malaria parasite |
| 09/29/1998 | US5814604 A pair of polypeptide chains disulfide bonded to form a dimeric species |
| 09/29/1998 | US5814510 Attenuated canine parvovirus vaccine |
| 09/29/1998 | US5814486 Herpes simplex virus glycoprotein D variants |
| 09/29/1998 | US5814477 Recombinant clostridial toxin protein |
| 09/29/1998 | US5814476 Producing a library of expression vectors; transforming; amplification; screening; isolation |
| 09/29/1998 | US5814475 Antibodies and dna for drugs and diagnosis |
| 09/29/1998 | US5814464 Nucleic acids encoding TIE-2 ligand-2 |
| 09/29/1998 | US5814459 Phosphospecific transcription factor antibodies |
| 09/29/1998 | US5814458 Immunoassay methods for the detection of HIV-1 antibodies employing envelope muteins containing hypervariable domain deletions |
| 09/29/1998 | US5814456 Sperm antigen corresponding to a sperm zone binding protein autoantigenic epitope |
| 09/29/1998 | US5814455 Helicobacter and antigens for detection for elisa, latex agglutination and analyzing |
| 09/29/1998 | US5814441 HTLV-I and HTLV-II peptide antigens and methods |
| 09/29/1998 | US5814321 Oil adjuvant vaccine and method for preparing same |
| 09/29/1998 | US5814320 Eimeria tenella polypeptide and vaccine containing same |
| 09/29/1998 | US5814317 Structural alterations of the EGF receptor gene in human gliomas |
| 09/29/1998 | US5814316 Administering an antibody to reverse choleocystokinin |
| 09/29/1998 | US5814295 Determination of lymph nodes enriched in tumor reactive cells their proliferation and their use in adoptive cellular therapy |
| 09/29/1998 | CA2118032C Therapeutic conjugates of toxins and drugs |
| 09/29/1998 | CA1340062C Method of inactivating reproductive filterable pathogens |
| 09/27/1998 | CA2231055A1 Interleukin-1 beta converting enzyme like apoptosis protease-10 |
| 09/24/1998 | WO1998041656A1 Compositions and method for the early diagnosis of ovarian cancer |
| 09/24/1998 | WO1998041641A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 09/24/1998 | WO1998041635A1 Human tumorigenesis associated protein, htap |
| 09/24/1998 | WO1998041629A2 Death domain containing receptor 5 |
| 09/24/1998 | WO1998041625A1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 09/24/1998 | WO1998041619A1 Attenuated polioviruses |
| 09/24/1998 | WO1998041536A1 Glycosylation deficient siv and hiv envelope glycoproteins |
| 09/24/1998 | WO1998041535A2 Activation of peptides |
| 09/24/1998 | WO1998041235A1 Use of avian antibodies |
| 09/24/1998 | WO1998041234A1 Novel compounds |
| 09/24/1998 | WO1998041233A1 Novel compounds |
| 09/24/1998 | WO1998041232A2 Compositions for modulating responsiveness to corticosteroids |
| 09/24/1998 | WO1998041228A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/24/1998 | WO1998041188A2 Stable particle in liquid formulations |
| 09/24/1998 | CA2644454A1 Death domain containing receptor 5 |
| 09/24/1998 | CA2284062A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/24/1998 | CA2283737A1 Human tumorigenesis associated protein, htap |
| 09/24/1998 | CA2283638A1 Attenuated polioviruses |
| 09/24/1998 | CA2282845A1 Methods and compositions for modulating responsiveness to corticosteroids |
| 09/23/1998 | EP0866133A2 A group b streptococcus vaccine |
| 09/23/1998 | EP0866131A2 Humanized anti-human fas antibody |
| 09/23/1998 | EP0866126A1 CDNA clone HNFDY20 that encodes a novel human 7-transmembrane receptor |
| 09/23/1998 | EP0866124A2 Composition containing a compound modifying directly or indirectly the activity of endogenous T1-M protein |
| 09/23/1998 | EP0865791A1 Use of Pasteurella haemolytica serotype A6 for the preparation of a vaccine against cattle pasteurellosis caused by Pasteurella haemolytica |
| 09/23/1998 | EP0865609A1 Method of diagnosing and treating epithelioma |
| 09/23/1998 | EP0865492A1 Specific binding members for human carcinoembryonic antigen, materials and methods |
| 09/23/1998 | EP0865491A1 Compounds having lectin properties and biological uses thereof |
| 09/23/1998 | EP0865448A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 09/23/1998 | EP0865298A1 Drug therapy |
| 09/23/1998 | EP0865297A1 Vaccine compositions for intranasal administration comprising chitosan and use thereof |
| 09/23/1998 | EP0865296A1 Influenza vaccine |
| 09/23/1998 | EP0865293A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/23/1998 | EP0749481B1 Humanized monoclonal antibodies against human interleukin-4 |
| 09/23/1998 | EP0627002B1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 09/23/1998 | CN1194009A 结肠特异性基因及蛋白质 Colon-specific genes and proteins |
| 09/23/1998 | CN1194005A Method for producing influenza hemagglutinin multivalent vaccines |
| 09/23/1998 | CN1194001A Neutralizing conformational epitopes of chicken anemia virus |
| 09/23/1998 | CN1194000A Methods for enhancement of protective immune responses |
| 09/23/1998 | CN1193995A Separation and concentration systems based on soluble oligosaccharide binding domains |